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ABSTRACT 
Background and Objectives: The structural significance of the inappropriateness of left ventricular mass (iLVM) 
is known to be an important prognostic factor for cardiovascular events; however, the functional changes associ-
ated with iLVM have not been established. This study was performed to determine if diastolic dysfunction is asso-
ciated with iLVM using a tissue Doppler technique. Subjects and Methods: Three hundred sixty consecutive sub-
jects, including 221 hypertension patients from the echocardiography database, were analyzed. Regarding the ap-
propriateness of left ventricular (LV) mass, an observed/predicted ratio of LV mass (OPR) >130% was defined as inap-
propriate. Echocardiographic parameters, including early diastolic peak velocity (E)/late diastolic peak velocity (A), 
deceleration time (DT), isovolumetric relaxation time (IVRT), and E/early mitral annulus velocity (E’), were com-
pared between the appropriate LV mass (aLVM) group and the iLVM group. Results: Among transmitral flow 
parameters, only the E velocity was negatively correlated with the OPR when adjusted for age (adjusted r=-0.107, 
p=0.04). Based on multiple regression analysis, the OPR (β=0.163, p=0.003), as well as age (β=0.286, p= 
0.0001), systolic blood pressure (β=0.120, p=0.019), fasting blood glucose (β=0.098, p=0.042), and male gender 
(β=0.157, p=0.002) were independent factors determining E/E’. The cholesterol level was not an independent 
factor (β=-0.059, p=0.355). In the iLVM group (n=105), the adjusted E/E’ was higher than in the aLVM group 
(n=255; 11.7±3.4 vs. 10.8±3.1, p=0.02), while the peak E flow velocity was significantly lower than in the aLVM 
group (70.9±15.1 vs. 75.5±17.6, p=0.03). Conclusion: Inappropriateness of LV mass is independently associated 
with increased E/E’. Thus, E/E’ may be a useful parameter for the evaluation of diastolic dysfunction. (Korean Circ 
J 2009;39:138-144) 
 





Left ventricular hypertrophy (LVH) is a well-known 
prognostic factor for cardiovascular events.
1) Left ventri-
cular (LV) mass is influenced by hemodynamic factors, 
such as high blood pressure and stroke work, as well as 
constitutional factors, such as body size and gender.
2) 
Inappropriateness of LV mass (iLVM) is defined in cases 
in which the degree of LVH is excessive considering he-
modynamic and constitutional factors, and it may be 
represented by the percent ratio of the observed LV 
mass to the predicted LV mass by height, gender, and st-
roke work. Blood pressure, which is important in the 
development of LVH, is included in the equation for 
stroke work calculation. 
Inappropriateness of LV mass has been reported to 
be an independent prognostic factor, regardless of the 
presence of LVH or not.
3) Inappropriately or excessively 
increased LV mass is associated with metabolic abnor-
mality, systolic dysfunction, and concentric geometry of 
LV, which is independent of the presence of hyperten-
sion.
4-6) iLVM has also been reported to be associated 
with diastolic dysfunction, which can be demonstrated 
using various transmitral blood flow parameters.
7) While 
the functional implication of iLVM is an important issue, 
there may be an argument for this association because 
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of the intrinsic limitations of the transmitral flow para-
meters. The objective of this study was to clarify the re-
lationship between iLVM and diastolic dysfunction using 
a tissue Doppler technique which is more reliable than 
transmitral blood flow parameters. 
 
Subjects and Methods 
 
In a cross-sectional design, data from 360 consecutive 
patients, including 221 hypertensive patients with or wi-
thout hypercholesterolemia, were analyzed. The dataset 
was acquired by applying exclusion criteria to a conse-
cutive patient echocardiography database, including 
2,515 patients from 1 December 2004 to 31 August 2005 
at Hanyang University Hospital in Seoul, Korea. Exclu-
sion criteria included poor acoustic image quality, M-
mode interrogation angle >10° , any regional wall motion 
abnormalities, grade II or greater valvular regurgitation, 
any valvular stenosis, ejection fraction <50%, pericardial 
disease, cardiomyopathy based on the echocardiographic 
findings, atrial fibrillation, creatinine level >1.5 mg/dL 
for males and 1.4 mg/dL for females, hemoglobin <13 
mg/dL in males and <12 mg/dL in females, clinical his-
tory of angina, congestive heart failure, known coronary 
artery disease, and incomplete clinical data. 
During the study period, height, weight, abdominal 
circumference, blood pressure, and heart rate were meas-
ured before echocardiography was performed. Blood 
pressure was measured 2 times with 1 minute interval 
using an A&D UA-767 (AND, Japan) and the averaged 
value was used for analysis. Abdominal circumference 
was measured at the mid-level of the abdomen between 
the iliac crest and the lower costal margin with a spring-
loaded measuring tape in the sitting or standing posi-
tion, according to the World Health Organization gui-
delines.
8) Duplicate measurements were made in all 
cases and the average was used for analysis unless there 
was <3% difference between the measurements, in which 
case the measurement was not used for analysis. The 
levels of total cholesterol, triglycerides, high density lipo-
protein (HDL), fasting blood glucose (FBG), and serum 
creatinine were obtained from the medical records. The 
study protocol was approved by the Institutional Review 
Board of Hanyang University Medical Center. Infor-
med consent was obtained from each patient regarding 
the process of the examination and use of the data. 
Abdominal obesity was defined by abdominal circum-
ference  ≥80 cm in females and ≥90 cm in males with 
the Asia-Pacific perspective.
9) Metabolic syndrome was 




Two-dimensional and guided M-mode echocardio-
grams were performed on each subject by a single sono-
grapher with a commercially available machine (IE-33; 
Philips) with a 1-5 MHz transducer. Measurements for 
M-mode-guided calculations of L V mass were taken at 
or just below the tip of the mitral valve with a paper 
speed of 50 mm/sec. The LV internal end-diastolic di-
mension (EDD), the end systolic dimension (ESD), and 
the septal and posterior wall thicknesses (PWT) were 
measured on the leading edge-to-the leading edge, accord-
ing to the guidelines of the American Society of Echo-






Doppler echocardiographic recordings were performed 
by pulsed-wave Doppler with the sample volume at the 
tips of the mitral valve in the apical four-chamber view 
and recorded at a paper speed of 100 mm/sec. Early (E) 
and late (A) diastolic peak velocities, deceleration time 
(DT), and early-to-late diastolic peak velocity ratio (E/A) 
were determined, as previously reported.
12) For patients 
<55 years of age, impaired relaxation was diagnosed if 
the E/A ratio <1 or the DT ≥240 ms. For older patie-
nts, both an E/A ratio <0.8 and a DT  ≥240 ms were 
required to diagnose impaired relaxation.
13) Early mitral 
annulus velocity (E’) was measured at the septal portion 
of the mitral annulus in an apical four chamber view 
using a tissue Doppler technique with a Nyquist limit of 
15 cm/s. 
 
Appropriateness of left ventricular mass 
Appropriateness of LV mass (aLVM) was expressed as 
the observed/predicted ratio (OPR) of the LV mass.
3) The 
predicted LV mass was calculated as previously describ-
ed.
14) Briefly, the LV mass was predicted by the following 
equation: 54.9+7.62×height (m
2.7)+0.67×stroke work 
(g-m/beat)-13.2×gender (male=1, female=2) (const-
ant=54.9±14.7 g, adjusted R
2=0.576, SEE=21.67, p= 
0.001). 
We adopted the LV mass index by the height to high-
light the effect of weight and set the cut-off value 
(mean+2 SD) for LVH as 54 g/m
2.7 for both genders. 
The cut-off value between the iLVM and aLVM groups 
was 130% or higher for both genders. 
 
Statistical analysis 
Data were expressed as the mean±SD. For the simple 
analysis of general characteristics and the gender differ-
ence, chi-square and independent t-tests were performed. 
Comparing the means among groups, age, gender, body 
mass index (BMI), systolic blood pressure (SBP), heart 
rate, fasting blood glucose (FBG) and the type of antihy-
pertensive therapy {using indicator variables for angioten-
sin-converting enzyme (ACE) inhibitors or angiotensin 
II receptor antagonists, other anti-hypertensive drugs, 
and no drug therapy} were adjusted using the least squ-
are means or a univariate general linear model for each 
dependent variable. Least squares multiple linear regres- 
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sion analysis (stepwise procedure) was used to evaluate 
the relationships, with assessment of in-model tolerance 
to evaluate multiple-collinearity. The minimal accepted 
tolerance was 0.70. A two-tailed p<0.05 was considered 
to be statistically significant. Data were analyzed using 
Statistical Package for Social Science (SPSS) 12.0 software 




General characteristics of the subjects 
The average age of the subjects was 58.1±13.9 years 
(range, 19-87 years). Two hundred of the subjects (55.5%) 
were females. Two hundred twenty-one of the subjects 
(61.3%) had hypertension, 71 (19.7%) had diabetes melli-
tus, 72 (20%) had hypercholesterolemia, and 106 (29.4%) 
had no risk factors. Thirty-nine patients (10.8%) had 
both hypertension and diabetes. Thirty-one patients 
(8.9%) had both hypertension and hypercholesterolemia. 
Four patients (1.1%) had both diabetes and hypercho-
lesterolemia. Nineteen patients (5.2%) had hypertension, 
diabetes, and hypercholesterolemia. One hundred sev-
enty patients (47.2%) had metabolic syndrome. Abdom-
inal obesity was noted in 249 (69.1%) patients. 
Among 221 hypertensive patients, 144 (65.1%) were 
on medical treatment; specifically, 68 patients (30.7%) 
were taking a prescription, including an angiotensin con-
verting enzyme inhibitor or an angiotensin receptor an-
tagonist, and 76 patients (34.4%) were taking other types 
of antihypertensive drugs. 
In a comparison of general characteristics between the 
male and female patients, the average age of the female 
patients was older (61.3±13.7 vs. 54.4±13.9 years, p= 
0.0001). The age-adjusted systolic and diastolic blood 
pressures were higher in male patients. The frequencies 
of increased BMI, diabetes mellitus, and hypercholes-
terolemia were similar in males and females. In female 
patients, the degree of abdominal obesity was much 
higher compared with male patients (83.8% vs. 50.6%) 
(Table 1). 
 
Clinical characteristics between the appropriate-
ness and inappropriateness of left ventricular mass 
groups 
In 217 subjects (60.3%), the LVs were normal with re-
spect to both the LV mass index and the appropriateness. 
Forty-six patients (12.8%) had inappropriate LV mass 
with a normal LV mass index. Thirty-eight patients 
(10.5%) had appropriate LV mass with an abnormal LV 
mass index and 59 patients (16.4%) had inappropriate 
LV mass and abnormal LV mass index. Among all the 
patients, 105 patients (29.1%) had inappropriate LV mass 
and 255 patients (70.9%) had appropriate LV mass 
(Table 2). 
Table 1. General characteristics of subjects 
  Male (n=160)  Female (n=200)  p 
Age 54.4±13.9 61.1±13.7  <0.0001 
Height (cm)  167.6±5.7 153.4±6.0  <0.0001* 
Weight (kg)  69.3±10.9 58.7±8.8  <0.0001* 
Body mass index (kg/m
2) 24.6±3.3 24.9±3.7  <0.38* 
Abdominal circumference (cm)  89.4±9.1 89.6±10.4  <0.87* 
Systolic blood pressure (mmHg)  129.2±17.3 125.6±21.4  <0.0001* 
Diastolic blood pressure (mmHg)  82.9±11.7 80.3±14.3  <0.0001* 
Heart rate (beats per minute)  68.8±11.6 70.0±12.3  <0.38* 
Total cholesterol (mg/dL)  181.6±39.0 197.5±38.3  <0.0001* 
Fasting blood glucose (mg/dL)  113.7±37.5 109.9±37.1  <0.35* 
Creatinine (mg/dL)  0.98±0.13 0.80±0.15  <0.0001* 
Triglycerides (mg/dL)  150.4±80.7 144.8±84.0  <0.58* 
HDL (mg/dL)  36.9±10.2 41.4±12.1  <0.002 
Hemoglobin (mg/dL)  14.0±1.2 12.5±1.1  <0.0001* 
LV mass index (g/m
2.7) 46.7±11.2 50.4±14.6  <0.006* 
OPR (%)  112.8±18.8 122.7±21.7  <0.0001* 
Abdominal obesity (%)  50.6  83.8  <0.004 
BMI >25 kg/m
2 (%) 44.9  46.9  <0.71* 
Hypertension (%)  69.1  54.9  <0.006* 
Diabetes mellitus (%)  21.7  18.5  <0.45* 
Hypercholesterolemia (%)  18.9  20.8  <0.66* 
LV mass index ≥54 g/m
2.7 (%) 20.8  36.8  <0.0001* 
OPR of LV mass ≥130% (%)  19.6  36.8  <0.0001* 
Continuous values are the mean±SD. *p<0.05 adjusted for age. HDL: high density lipoprotein, LV: left ventricular, OPR: observed/predicted 
ratio of LV mass, BMI: body mass index    
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Patients with iLVM were older (63.0±11.8 vs. 56.1±
14.2 years, p=0.0001) and more likely to be female 
(73.3% vs. 48.0%, p=0.0001). In the iLVM group, BMI 
(26.0±3.2 vs. 24.3±3.6, p=0.0001) and total choleste-
rol (201.6±36.2 vs. 185.1±36.5 mg/dL, p=0.001) was 
higher. The frequencies of abdominal obesity (74.0% vs. 
68.4%), diabetes mellitus (23.4% vs. 18.5%) and hyper-
tension (58.2% vs. 62.4%) were not different when ad-
justed for age and gender (Table 3). 
 
Observed/predicted ratio versus transmitral flow 
pattern 
Among transmitral blood flow parameters, only iso-
volumetric relaxation time (IVRT) showed a correlation 
with OPR in males. In female patients, E, A, E/A, and 
IVRT showed an association with OPR (Table 4). For 
both genders, however, only the inverse relationship 
between E velocity and OPR, when adjusted by age, was 
significant among the transmitral flow parameters (Table 5). 
Table 2. Clinical characteristics of subjects 
    LV appropriateness (OPR) 
    aLVM  iLVM 
Total 
Normal (%)  217 (60.3)  46 (12.8)  263  LV mass 
index  Abnormal (%)  38 (10.5)  59 (16.4)  097 
Total  255  105  360 
LV: left ventricular, OPR: observed/predicted ratio of left ventricular
mass, aLVM: appropriate LV mass, iLVM: inappropriate LV mass 
 
Table 3. Comparison between groups of appropriate LV mass (aLVM) versus inappropriate LV mass (iLVM) 
  aLVM (n=255)  iLVM (n=105)  p 
Age 56.1±14.2 63.0±11.8 0.0001 
Female (%)  48.0  73.3  0.0001 
Body mass index (kg/m
2) 24.3±3.6 26.0±3.2 0.0001 
Abdominal circumference (cm)  90.0±9.86 89.3±9.8 0.40 
Systolic blood pressure (mmHg)  129.9±19.7 120.6±17.1 0.0001 
Diastolic blood pressure (mmHg)  83.6±13.6 77.3±11.8 0.0001 
Heart rate (beats per minute)  69.6±11.7 69.0±12.7 0.45 
Total cholesterol (mg/dL)  185.1±36.5 201.6±36.2 0.001 
Fasting blood glucose (mg/dL)  109.8±35.1 116.0±41.4 0.14 
Creatinine (mg/dL)  0.89±0.17 0.87±0.15 0.51 
Triglycerides (mg/dL)  142.8±77.5 160.0±91.5 0.14 
HDL (mg/dL)  38.6±10.5 40.8±13.4 0.16 
Hemoglobin (mg/dL)  13.1±1.4 13.2±1.4 0.32 
Hypercholesterolemia (%)  17.0  29.9  0.01 
Diabetes mellitus (%)  18.5  23.4  0.34 
Hypertension (%)  62.4  58.2  0.48 
Abdominal obesity (%)  68.4  74.0  0.22 
Body mass index >25 kg/m
2 (%) 41.0  58.1  0.002 
Continuous values are the mean±SD adjusted by age, gender, body mass index, systolic blood pressure, heart rate, fasting blood glucose level, and the
type of antihypertensive therapy. HDL: high density lipoprotein, LV: left ventricle, DT: deceleration time, IVRT: isovolumetric relaxation time 
 
Table 4. Pearson correlation coefficients between age, SBP, BMI, OPR, FBG, and echocardiographic parameters 
  E  A  DT  IVRT  E/A  E/E’ 










‡ 0.084  0.043  -0.210
‡  -0.103 
BMI  -0.075 0.260
†  0.108 0.072 -0.234*  -0.224* 
OPR  -0.254
† 0.145




FBG  -0.080 0.321  0.139 0.142 -0.261
†  -0.203
‡ 
Female            
Age  -0.262* 0.520*  0.289* 0.252*  -0.618*  -0.359
† 
SBP 0.008 0.256  0.095  -0.024  -0.206
‡  -0.218
‡ 
BMI  -0.085  -0.142  -0.020  -0.042 0.020  -0.063 
OPR  -0.115 0.018  -0.041 0.168
§  -0.115  -0.187
§ 
FBG  -0.120 0.157  0.064  0.098 -0.190  -0.069 
*p=0.001,  †p<0.001,  ‡p<0.01,  §p<0.05. SBP: systolic blood pressure, BMI: body mass index, OPR: observed/predicted ratio of left ventricular 
mass, FBG: fasting blood glucose, E: early diastolic peak velocity, A: late diastolic peak velocity, E’: early mitral annulus velocity, DT: deceleration 
time, IVRT: isovolumetric relaxation time 
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Observed/predicted ratio versus early diastolic 
peak velocity/early mitral annulus velocity 
The age, BMI, FBG level, and OPR were significantly 
correlated with E/E’ in male patients. The age, SBP, and 
OPR were significantly correlated with E/E’ in female 
patients (Table 4). In multiple regression analysis, age 
(β=0.286, p=0.0001), SBP (β=0.120, p=0.019), FBG 
(β=0.098, p=0.042), male gender (β=0.157, p=0.002), 
and OPR (β=0.163, p=0.003) were independent factors 
for E/E’. The cholesterol level was not an independent 
factor (β=-0.059, p=0.355). 
 
Comparison between groups 
When adjusted by age, gender, BMI, SBP, cholesterol 
level, FBG, and types of antihypertensive medications, 
both the diastolic LV dimension (5.06±0.46 vs. 4.91±
0.44, p=0.007) and the relative wall thickness (0.38±
0.04 vs. 0.33±0.04, p<0.0001) were higher in the iLVM 
group. In the iLVM group, peak E flow velocity was 
significantly lower than in the aLVM group (70.9±15.1 
vs. 75.5±17.6, p=0.03), as well as E’ velocity (6.59±
2.04 vs. 7.34±1.50 cm/sec, p=0.001). E/E’ was higher 
in iLVM group (11.7±3.4 vs. 10.8±3.1, p=0.02) (Ta-
ble 6) (Fig. 1). The E/E’ was 10.7±0.2 in normal LV 
mass, 10.9±0.5 in patients with iLVM without LVH, 
11.2±0.5 in appropriate LVH patients, and 12.1±0.4 
in inappropriate LVH patients {analysis of variance (A-
NOVA), p=0.02}. 
Table 5. Age-adjusted correlation coefficients between LV structure and diastolic function
  E  A  DT  IVRT  E’  E/A  E/E’ 
LVM (g)  -0.017 0.086  -0.069 0.053  -0.160*  -0.023 0.098 
LVMI (g/m
2)  -0.035 0.002  -0.063 0.037  -0.178
†  -0.002 0.173
† 
LVMI (g/m
2.7)  -0.017 0.086  -0.069 0.026  -0.225
‡  -0.041 0.238
‡ 
OPR (%)  -0.107* 0.033 -0.024 0.100  -0.228
‡  -0.102 0.187* 
*p<0.05,  †p=0.001, ‡p<0.001. LV: left ventricular, LVM: left ventricular mass, LVMI: left ventricular mass index, OPR: observed/predicted ratio of
left ventricular mass, E: early diastolic peak velocity, A: late diastolic peak velocity, DT: deceleration time, IVRT: isovolumic relaxation time, E’: early 
mitral annulus velocity 
 
Table 6. Left ventricular dimensions and diastolic properties
  aLVM (n=255)  iLVM (n=105)  p 
LV diastolic dimension (cm)  4.91±0.44 5.06±0.46  <.007 
Relative wall thickness (cm)  0.33±0.04 0.38±0.04  <.0001 
LV mass (gram)  157.5±39.2 207.2±44.8  <.0001 
LV mass index (gram/m
2.7) 44.7±10.9 59.8±12.5  <.0001 
OPR (%)  109.1±13.2 141.4±11.6  <.0001 
Ejection fraction (%)  68.8±5.72 66.8±4.91 0.005 
LA dimension (cm)  3.28±0.53 3.45±0.58 0.17 
Peak E flow velocity (cm/sec)  75.5±17.6 70.9±15.1 0.03 
Peak A flow velocity (cm/sec)  77.8±18.2 77.0±18.7 0.68 
Peak E/A velocity ratio  1.02±0.38 0.97±0.30 0.15 
E velocity deceleration time (msec)  214.3±43.2 208.9±44.3 0.34 
Isovolumetric relaxation time (msec)  80.7±13.9 82.2±15.2 0.43 
E’ velocity (cm/sec)  7.34±1.50 6.59±2.04 0.001 
Impaired relaxation (%)  19.9  24.7  0.39 
E/E’ 10.8±3.1 11.7±3.4 0.02 
Continuous values are the mean±SD adjusted by age, gender, BMI, systolic blood pressure, heart rate, fasting blood glucose level, and the
type of antihypertensive therapy. LA: left atrium, LV: left ventricular, OPR: observed/predicted ratio of LV mass, E: early diastolic peak velocity, A:
late diastolic peak velocity, E’: early mitral annulus velocity, BMI: body mass index 
 
Fig. 1. Adjusted E/E’ by age, gender, BMI, systolic blood pres-
sure, cholesterol level, fasting blood glucose level, and types of 
antihypertensive medication is significantly higher in the inappro-
priate LV mass group than the appropriate LV mass group. E:
early diastolic peak velocity, E’: early mitral annulus velocity, BMI:
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Discussion 
 
This study was designed to clarify the functional sig-
nificance of the inappropriately increased LV mass using 
a tissue Doppler technique, in addition to the traditional tr-
ansmitral flow parameters. The results showed that the 
appropriateness of LV mass is an independent factor de-
termining E/E’, along with age, SBP, gender, and FBG 
level. The adverse influence of inappropriate LV mass 
was evidenced by the finding that the adjusted E/E’ va-
lue was higher in the iLVM group. In the iLVM group, 
the E velocity was lower, and the E’ velocity was even 
lower. Accordingly, the resultant E/E’ was lower in the 
iLVM group than the aLVM group. 
In contrast, with respect to the transmitral flow para-
meters, only the inverse correlation between the OPR 
and the transmitral E velocity was significant when ad-
justed for age. The borderline statistical significance for 
IVRT may be attributable to the smaller sample size com-
pared to a previous study.
7) Transmitral flow parameters 
are widely used for practicality reasons; however, the 
non-linearity associated with LV function deterioration 
make it difficult to interpret the functional relevance of 
the structural changes of the LV. E/E’ is advantageous 
because of its linear relationship with the left atrial pres-
sure or brain natriuretic peptide (BNP). 
Some authors have pointed out that the indexation 
methods of LV mass (e.g., indexation by body surface 
area or height
2.7) have a different clinical significance.
20) 
Of note, the functional aspect of these different indexa-
tions has not been clarified. Our study showed that age-
adjusted partial correlation coefficients between E/E’ and 
LV mass, regardless of using different indexations, were 
consistently significant, as well as the OPR of the LV 
mass (Table 5). 
Age, gender and the LV mass are well-known con-
tributors for E’ velocity or E/E’.
21)22) There may be an 
argument against the suggestion that the OPR of the LV 
mass have additional value to the traditionally defined 
LV hypertrophy regarding the influence on diastolic dys-
function. In our study, the correlation coefficients of 
the OPR versus LVM, LVMI indexed by body surface 
area, and LVMI indexed by height
2.7 were similar (0.502, 
0.590, and 0.647, respectively); however, the correlation 
coefficient between LVMI indexed by body surface area 
and LVMI indexed by height
2.7 (0.928) was in contrast 
with the OPR and LVMI indexed by height (0.68)
2.7. 
With the limitation that the number of patients in 
the study did not allow multiple comparisons among gr-
oups, only in the inappropriate LVH group, the E/E’ 
value was higher than the group of normal LV mass. The 
E/E’ in iLVM without LVH or aLVH was not statistically 
different from that of the normal LV mass group. These 
findings suggest that inappropriateness of LV mass is 
functionally more important in LVH patients. There 
might be an additive or synergistic interaction between 
LVH and the appropriateness of LV mass. For sufficient 
statistical analysis of the interaction between appropri-
ate LVH and inappropriate LVM, a study with a larger 
sample size is needed. 
LV dysfunction was demonstrated in patients with pre-
hypertension, and even in normotensive patients
23) and 
the additive effect of diabetes on myocardial dysfunction 
in hypertension was also reported.
24) These findings sug-
gest that there may be other factors affecting LV dys-
function than blood pressure itself. In our study, ano-
ther consistent finding with the previously reported data 
is that BMI was much higher in the iLVM group.
4) The 
prevalence of abdominal obesity was not different betw-
een the groups. This may be attributable to the Asian 
Pacific criteria for abdominal obesity.
9) Using these crite-
ria, the prevalence in the population was relatively high
25) 
and there is a suggestion for a new cutoff value for abdo-
minal obesity for the Korean population.
26) Another po-
ssible explanation may be that abdominal obesity may be 
an early sign of obesity and the difference between abdo-
minal obesity is evident only before overt obesity devel-
ops.
14) Even though our data derived from the database 
of the echocardiography laboratory and hospital records 
included quite heterogeneous subjects, other parameters 
associated with iLVM, such as anemia, renal insufficiency, 
and thyroid dysfunction were excluded very cautiously. 
Thus, regarding LV diastolic function, the inappropria-
teness of LV mass might be another factor to be conside-
red in addition to the presence or absence of LVH in pa-
tients with a wide spectrum of cardiovascular risk factors. 
In conclusion, inappropriateness of LV mass is func-
tionally associated with LV dysfunction and high left 
atrial pressure. 
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